Banagan, Mutasim T.
HRN: 21-59-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/20/2022
07/20/2022
IV
230mg
Q8h
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes